Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10135 |
| Vaccine Name | Varivax |
| Disease Name | Chickenpox |
| Disease Classification | Exanthous |
| Virus Name | Varicella-zoster virus |
| Nucleic Acid Content | double stranded DNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Approved |
| Manufacturer | Merck & Co. Inc. |
| Year of Manufacturing | 2007 |
| Manufacturing Country | USA |
| Age | 1 - 12 years |
| Dosage | 2 doses (0.5 ml each) separated by at least 3 months.# First dose: age 12 through 15 months, Second dose: age 4 through 6 years |
| Administration Route | Subcutaneous |
| Adjuvant | NA |
| Target Strain | Oka/Merck strain of live-attenuated varicella virus |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT00822237 |
| Reference Link | https://www.cdc.gov/vaccines/vpd/varicella/index.html |
| Additional Links | https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax |